Benzalkonium Chloride Demonstrates Concentration-Dependent Antiviral Activity Against Adenovirus .

Authors:
Eric G Romanowski
Eric G Romanowski
University of Pittsburgh School of Medicine
United States
Kathleen A Yates
Kathleen A Yates
The Charles T. Campbell Eye Microbiology Laboratory
Regis P Kowalski
Regis P Kowalski
Charles T. Campbell Ophthalmic Microbiology Laboratory

J Ocul Pharmacol Ther 2019 Jun 10;35(5):311-314. Epub 2019 Apr 10.

The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Adenoviral conjunctivitis is the most common cause of conjunctivitis worldwide with no approved antiviral treatment. Benzalkonium chloride (BAK) is a common preservative in ophthalmic medications and is the active ingredient in some skin disinfectants and hand sanitizers. BAK is known to be effective in killing bacteria and enveloped viruses; however, its activity against ocular types of nonenveloped adenoviruses (Ads) is unknown. The goal was to determine whether BAK is an effective antiviral agent against common human ocular types of adenovirus . The direct inactivating activity of BAK was determined by incubating several human adenovirus types with BAK concentrations of 0.001%, 0.003%, 0.005%, 0.01%, 0.1%, and 0% for 1 h at 33°C. Resulting adenovirus titers were determined after treatment. Decreases in titers of ≥3 Log were considered virucidal, while decreases in titers of <1 Log were considered ineffective. BAK 0.1% was virucidal for Ad3, Ad5, Ad7a, Ad19/64, and Ad37, while it reduced titers >1 Log, but <3 Log for Ad4 and Ad8. Decreases in titers >1 Log were demonstrated for BAK 0.003%, 0.005%, and 0.01% for Ad5 only. Decreases in titers for the other adenovirus types for those concentrations were ≤0.53 Log. 0.001% BAK produced minimal decreases in titers for all types. BAK, at 0.01% or less was not consistently effective as an antiviral against adenovirus, but higher concentrations, such as 0.1%, should be further investigated as a possible topical treatment for adenoviral ocular infections, providing ocular toxicity is not an issue.

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/jop.2018.0145
Publisher Site
http://dx.doi.org/10.1089/jop.2018.0145DOI Listing
June 2019
6 Reads

Publication Analysis

Top Keywords

decreases titers
16
bak effective
8
bak
8
types bak
8
adenovirus types
8
ocular types
8
benzalkonium chloride
8
0003% 0005%
8
0005% 001%
8
effective antiviral
8
adenovirus
6
titers
5
types
5
1 h 33°c
4
01% 1 h
4
33°c adenovirus
4
adenovirus titers
4
titers ≥3
4
log
4
treatment decreases
4

Similar Publications